IP Library Granted Patent US 8,921,041
Granted Patent B2
US 8,921,041 · App. 13/474,355 · Granted Dec 30, 2014

Device and method for electroporation-based delivery of molecules into cells and dynamic monitoring of cell responses

Inventors: Xiaobo Wang (San Diego, CA); Yama A. Abassi (San Diego, CA); Josephine Atienza (San Diego, CA); Xiao Xu (San Diego, CA); Junquan Xu (San Diego, CA)
Assignee: ACEA Biosciences, Inc.
C12N15/87C12M35/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,921,041
App. No.
13/474,355
Granted
Dec 30, 2014
Kind
B2
Abstract

The present invention includes devices and methods for transfecting a cell or cell population and dynamic monitoring of cellular events. A variety of microelectronic devices are provide that incorporate functions such as electroporation, modulation of a transmembrane potential and dynamic monitoring of cellular functions and mechanisms.

Claims (56)

1. A method of monitoring a cellular response in real time comprising:

a. introducing a cell or cell population to a substrate comprising impedance monitoring electrodes;

b. transfecting the cell or cell population with a molecule using a transfection method selected from the group consisting of a viral transfection method, a chemical transfection method, and a thermal transfection method; wherein the molecule is capable of effecting at least one selected from the group consisting of a cellular function, cell morphology, a cellular receptor, and a signal transduction pathway activated by a receptor; further wherein the cellular function is selected from the group consisting of cell proliferation cell adhesion and cell spreading; and

c. monitoring impedance of the cell or cell population when the cell or cell population is in contact with at least one of the impedance monitoring electrodes.

2. A method of monitoring a cellular response in real time comprising:

a. introducing a cell or cell population to a substrate comprising impedance monitoring electrodes;

b. transfecting the cell or cell population with a molecule using a viral transfection method, wherein the viral transfection method is an adenovirus transfection method or a vaccinia virus transfection method; and

c. monitoring impedance of the cell or cell population when the cell or cell population is in contact with at least one of the impedance monitoring electrodes.

3. A method of monitoring a cellular response in real time comprising:

a. introducing a cell or cell population to a substrate comprising impedance monitoring electrodes;

b. transfecting the cell or cell population using a chemical transfection method, wherein the chemical transfection method is a lipid-mediated transfection method or an amine-based transfection method; and

c. monitoring impedance of the cell or cell population when the cell or cell population is in contact with at least one of the impedance monitoring electrodes.

4. A method of monitoring a cellular response in real time comprising:

a. introducing a cell or cell population to a substrate comprising impedance monitoring electrodes;

b. transfecting the cell or cell population with a molecule using a transfection method, wherein the transfection method is a thermal transfection method; and

c. monitoring impedance of the cell or cell population when the cell or cell population is in contact with at least one of the impedance monitoring electrodes.

5. The method according to claim 1 , wherein the cell is a eukaryotic cell or a mammalian cell.

6. The method according to claim 1 , wherein the molecule is selected from the group consisting of a DNA molecule, an RNA molecule, an oligopeptide, a polypeptide, a protein and a compound.

7. The method according to claim 6 , wherein the DNA molecule is selected from the group consisting of a recombinant DNA molecule, a native DNA molecule, a plasmid, a cDNA, an anti-sense DNA strand, and an oligonucleotide.

8. The method according to claim 6 , wherein the RNA molecule is selected from the group consisting of a siRNA molecule, a microRNA molecule, a native RNA molecule, a ribozyme RNA, and an aptamer.

9. The method according to claim 1 , wherein the molecule is a capable of affecting a member selected from the group consisting of transcription, translation, RNA splicing, and RNA editing.

10. The method according to claim 1 , wherein the molecule is capable of affecting the cellular function.

11. The method according to claim 1 , wherein the molecule is capable of affecting cell morphology.

12. The method according to claim 1 , wherein the molecule is capable of affecting the cellular receptor or signal transduction pathway activated by the receptor.

13. The method according to claim 10 , further comprising,

transfecting a cell or cell population with a control molecule;

monitoring the impedance of the cell or cell population transfected with the control molecule; and

comparing monitored impedances between the cell population transfected with the molecule and the cell population transfected with the control molecule;

wherein the control molecule is a molecule that has no direct effect on cellular function.

14. The method according to claim 1 , wherein the step of monitoring impedance comprises performing a series of impedance measurements.

15. The method according to claim 1 , further comprising monitoring impedance of the cell or cell population before the step of transfecting the cell or cell population.

16. The method according to claim 15 , further comprising determining the cell or cell population is to be transfected if at least one impedance measurement prior transfecting the cell or cell population is within a predetermined range.

17. The method according to claim 1 , wherein the steps of transfecting the cell or cell population and monitoring impedance are performed on a same device.

18. The method according to claim 1 , further comprising visually monitoring the cell or cell population while monitoring impedance of the cell or cell population.

19. The method according to claim 1 , further comprising detecting fluorescence of the cell or cell population.

20. The method according to claim 1 , further comprising determining a cell index or a change in cell index.

21. The method according to claim 1 , further comprising conducting an end point assay selected from the group consisting of a cell viability assay, an apoptosis assay, an enzymatic activity assay, a signal transduction analysis assay, and a reporter assay.

22. The method according to claim 21 , wherein an impedance measurement is used as a guide to determine a time for conducting the end-point assay.

23. A device for monitoring a cell or cell population comprising:

a) a multi-well plate, each well comprising a nonconductive substrate;

b) a plurality of electrode arrays positioned on the substrate, wherein each electrode array comprises at least two electrodes, further wherein each electrode is separated from at least one adjacent electrode by an area of non-conductive material; and

c) at least one set of electroporation or electrostimulation electrodes, the electroporation electrodes capable of electroporating a cell or the electrostimulation electrodes capable of affecting cell membrane potential.

24. The device according to claim 23 , wherein a first half of the set of electroporation or electrostimulation electrodes are in the plane of the substrate and a second half of the set of electrodes are not within the plane of the substrate.

25. The method according to claim 1 , wherein the transfection method is the viral transfection method, and is an adenovirus transfection method or a vaccinia virus transfection method.

26. The method according to claim 2 , further comprising monitoring impedance of the cell or cell population before the step of transfecting the cell or cell population.

27. The method according to claim 26 , further comprising determining the cell or cell population is to be transfected if at least one impedance measurement prior transfecting the cell or cell population is within a predetermined range.

28. The method according to claim 2 , wherein the molecule is capable of affecting a cellular function selected from the group consisting of cell proliferation, cell adhesion, and cell spreading or capable of affecting cell morphology.

29. The method according to claim 2 , further comprising conducting an end point assay selected from the group consisting of a cell viability assay, an apoptosis assay, an enzymatic activity assay, a signal transduction analysis assay, and a reporter assay.

30. The method according to claim 3 , further comprising monitoring impedance of the cell or cell population before the step of transfecting the cell or cell population.

31. The method according to claim 30 , further comprising determining the cell or cell population is to be transfected if at least one impedance measurement prior transfecting the cell or cell population is within a predetermined range.

32. The method according to claim 3 , wherein the molecule is capable of affecting a cellular function selected from the group consisting of cell proliferation, cell adhesion, and cell spreading or capable of affecting cell morphology.

33. The method according to claim 3 , further comprising conducting an end point assay selected from the group consisting of a cell viability assay, an apoptosis assay, an enzymatic activity assay, a signal transduction analysis assay, and a reporter assay.

34. The method according to claim 4 , further comprising monitoring impedance of the cell or cell population before the step of transfecting the cell or cell population.

35. The method according to claim 34 , further comprising determining the cell or cell population is to be transfected if at least one impedance measurement prior transfecting the cell or cell population is within a predetermined range.

36. The method according to claim 4 , wherein the molecule is capable of affecting a cellular function selected from the group consisting of cell proliferation, cell adhesion, and cell spreading or capable of affecting cell morphology.

37. The method according to claim 4 , further comprising conducting an end point assay selected from the group consisting of a cell viability assay, an apoptosis assay, an enzymatic activity assay, a signal transduction analysis assay, and a reporter assay.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 25, 2021
From: ACEA BIOSCIENCES, INC.
To: AGILENT TECHNOLOGIES, INC.
Reel/Frame 055409/0874 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 17, 2012
From: ABASSI, YAMA A.; WANG, XIAOBO; ATIENZA, JOSEPHINE; XU, XIAO; XU, JUNQUAN
To: ACEA BIOSCIENCES
Reel/Frame 028228/0935 →
Continuity (31)
Continuation 11286882 · Nov 23, 2005
Continuation In Part 11235938 · Sep 27, 2005
Continuation In Part 11197994 · Aug 4, 2005
Continuation In Part 11055639 · Feb 9, 2005
Continuation In Part 10987732 · Nov 12, 2004
Continuation In Part 10705447 · Nov 10, 2003
Continuation In Part 11198831 · Aug 4, 2005
Continuation In Part 10705615 · Nov 10, 2003
Provisional Application 60519567 · Nov 12, 2003
Provisional Application 60435400 · Dec 20, 2002
Provisional Application 60469572 · May 9, 2003
Provisional Application 60630131 · Nov 22, 2004
Provisional Application 60630071 · Nov 22, 2004
Provisional Application 60613872 · Sep 27, 2004
Provisional Application 60613749 · Sep 27, 2004
Provisional Application 60630809 · Nov 24, 2004
Provisional Application 60633019 · Dec 3, 2004
Provisional Application 60647159 · Jan 26, 2005
Provisional Application 60653904 · Feb 17, 2005
Provisional Application 60673678 · Apr 21, 2005
Provisional Application 60689422 · Jun 10, 2005
Provisional Application 60542927 · Feb 9, 2004
Provisional Application 60548713 · Feb 27, 2004
Provisional Application 60614601 · Sep 29, 2004
Provisional Application 60598608 · Aug 4, 2004
Provisional Application 60598609 · Aug 4, 2004
Provisional Application 60647189 · Jan 26, 2005
Provisional Application 60647075 · Jan 26, 2005
Provisional Application 60660829 · Mar 10, 2005
Provisional Application 60660898 · Mar 10, 2005
Related Publication 20120225424A1 · Sep 6, 2012